Abstract
Lee Schwartzberg, MD, FACP, and Heather Greene, MSN, FNP, AOCNP®, reviewed optimal therapy for patients with hormone receptor–positive, HER2-negative breast cancer, as well as the management of adverse events associated with treatment.
Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices
April 21, 2020
Volume 11, Number 3 (Apr 2020)
https://doi.org/10.6004/jadpro.2020.11.3.12
